ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 165 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2018. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $19,373,000 | -15.0% | 324,724 | +3.5% | 0.07% | +11.5% |
Q1 2022 | $22,784,000 | -13.6% | 313,744 | +0.0% | 0.06% | +1.7% |
Q4 2021 | $26,378,000 | -32.0% | 313,681 | -27.0% | 0.06% | -35.5% |
Q3 2021 | $38,773,000 | +11.5% | 429,906 | +17.8% | 0.09% | +10.7% |
Q2 2021 | $34,784,000 | -19.1% | 364,809 | -3.4% | 0.08% | -23.6% |
Q1 2021 | $43,019,000 | +106.1% | 377,826 | +38.2% | 0.11% | +89.7% |
Q3 2018 | $20,877,000 | +87.2% | 273,479 | +74.0% | 0.06% | +70.6% |
Q3 2016 | $11,150,000 | -32.4% | 157,176 | -53.4% | 0.03% | -34.6% |
Q2 2016 | $16,490,000 | +67.1% | 337,153 | +116.3% | 0.05% | +67.7% |
Q1 2016 | $9,869,000 | -68.5% | 155,883 | -44.3% | 0.03% | -67.0% |
Q4 2015 | $31,378,000 | +40.7% | 279,713 | +20.8% | 0.09% | +40.3% |
Q3 2015 | $22,303,000 | -70.1% | 231,580 | -68.2% | 0.07% | -65.8% |
Q2 2015 | $74,505,000 | +91.0% | 727,659 | +15.8% | 0.20% | +98.0% |
Q1 2015 | $39,013,000 | +108.0% | 628,332 | +47.0% | 0.10% | +106.2% |
Q4 2014 | $18,755,000 | -42.6% | 427,416 | -26.0% | 0.05% | -41.5% |
Q3 2014 | $32,694,000 | +57.1% | 577,631 | +24.6% | 0.08% | +241.7% |
Q2 2014 | $20,816,000 | +686.4% | 463,732 | +756.5% | 0.02% | +300.0% |
Q1 2014 | $2,647,000 | – | 54,144 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |